(B)(4). A REVIEW OF RECORDS RELATED TO THE DEVICE INCLUDING LABELING, COMPLAINT TRENDING, AND RISK DOCUMENTATION WILL BE PERFORMED. UPON COMPLETION OF THIS REVIEW, IF THERE IS ANY FURTHER RELEVANT INFORMATION OBTAINED, A SUPPLEMENTAL MEDWATCH WILL BE FILED. ALL PERTINENT INFORMATION AVAILABLE TO JOHNSON & JOHNSON SURGICAL VISION, INC. HAS BEEN SUBMITTED.
D
Patient 1
IT WAS REPORTED THAT A LASER VISION CORRECTION PATIENT HAD SURGERY ON (B)(6) 2020 AND PRESENTED ON (B)(6) 2020 COMPLAINING OF BLURRY VISION, HALOS, GLARES AND SHADOWS IN THE BOTH EYES, AS PATIENT HAD ACCIDENTALLY TOUCHED FLAPS. THE TOPICAL STEROID DOSAGE WAS INCREASED AND FLAP LIFT AND RINSE WAS PERFORMED ON (B)(6) 2020. IT WAS STATED THAT THE PATIENT HAD NO LOSS OF BEST CORRECTED VISUAL ACUITY (BCVA). PATIENT REPORTED SYMPTOMS ARE NOT INTERFERING WITH DAILY ACTIVITIES. BCVA FROM (B)(6) 2019. RIGHT EYE PRE-OP 20/20 -3.00 X -1.00 X 10. LEFT EYE PRE-OP 20/20 -4.00 X -.75 X 175.